Direct Oral Anticoagulants in Sickle Cell Disease
· One min read
Abstract
This research evaluates the safety profile of direct oral anticoagulants in patients with sickle cell disease and venous thromboembolism, focusing on bleeding incidence rates compared to traditional anticoagulation methods.